Cover Image
市場調查報告書

Genovate Biotechnology Co., LTD.:產品平台分析

Genovate Biotechnology Co., LTD. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 305693
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Genovate Biotechnology Co., LTD.:產品平台分析 Genovate Biotechnology Co., LTD. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 23 Pages
簡介

Genovate Biotechnology Co., Ltd.是提供新藥、開發新設計製劑、製造磷酸鳥甘(cGMP)藥、登計醫藥品、進行臨床實驗以及推出藥劑及配送的製藥公司。該公司的產品有 血液學、神經系統、泌尿器官系統、心血管系統· 消化管以及代謝等藥劑,還有抗菌劑與抗癌劑,也有針對代謝障礙和間歇性跛行的產品。同時更提供ODM及CMD服務、醫藥品銷售、行銷服務。

本報告提供Genovate Biotechnology Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Genovate Biotechnology Co., LTD.的基本資料

  • Genovate Biotechnology Co., LTD.概要
  • 主要資訊
  • 企業資料

Genovate Biotechnology Co., Ltd.:R&D概要

  • 主要的治療範圍

Genovate Biotechnology Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Genovate Biotechnology Co., Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Genovate Biotechnology Co., Ltd.:藥物簡介

  • sodium benzoate
  • DBPR-108
  • PCBB-7

Genovate Biotechnology Co., Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Genovate Biotechnology Co., Ltd.:最近的開發平台趨勢

Genovate Biotechnology Co., Ltd.:暫停中的計劃

Genovate Biotechnology Co., Ltd.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07466CDB

Summary

Global Markets Direct's, 'Genovate Biotechnology Co., LTD. - Product Pipeline Review - 2015', provides an overview of the Genovate Biotechnology Co., LTD.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Genovate Biotechnology Co., LTD.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Genovate Biotechnology Co., LTD. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Genovate Biotechnology Co., LTD.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Genovate Biotechnology Co., LTD.'s pipeline products

Reasons to buy

  • Evaluate Genovate Biotechnology Co., LTD.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Genovate Biotechnology Co., LTD. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Genovate Biotechnology Co., LTD.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Genovate Biotechnology Co., LTD. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Genovate Biotechnology Co., LTD.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Genovate Biotechnology Co., LTD. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Genovate Biotechnology Co., LTD. Snapshot
    • Genovate Biotechnology Co., LTD. Overview
    • Key Information
    • Key Facts
  • Genovate Biotechnology Co., LTD. - Research and Development Overview
    • Key Therapeutic Areas
  • Genovate Biotechnology Co., LTD. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Genovate Biotechnology Co., LTD. - Pipeline Products Glance
    • Genovate Biotechnology Co., LTD. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Genovate Biotechnology Co., LTD. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Genovate Biotechnology Co., LTD. - Drug Profiles
    • sodium benzoate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DBPR-108
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PCBB-7
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Genovate Biotechnology Co., LTD. - Pipeline Analysis
    • Genovate Biotechnology Co., LTD. - Pipeline Products by Target
    • Genovate Biotechnology Co., LTD. - Pipeline Products by Route of Administration
    • Genovate Biotechnology Co., LTD. - Pipeline Products by Molecule Type
    • Genovate Biotechnology Co., LTD. - Pipeline Products by Mechanism of Action
  • Genovate Biotechnology Co., LTD. - Recent Pipeline Updates
  • Genovate Biotechnology Co., LTD. - Dormant Projects
  • Genovate Biotechnology Co., LTD. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Genovate Biotechnology Co., LTD., Key Information
  • Genovate Biotechnology Co., LTD., Key Facts
  • Genovate Biotechnology Co., LTD. - Pipeline by Indication, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Stage of Development, 2015
  • Genovate Biotechnology Co., LTD. - Monotherapy Products in Pipeline, 2015
  • Genovate Biotechnology Co., LTD. - Phase II, 2015
  • Genovate Biotechnology Co., LTD. - Phase I, 2015
  • Genovate Biotechnology Co., LTD. - Preclinical, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Target, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Route of Administration, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Molecule Type, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline Products by Mechanism of Action, 2015
  • Genovate Biotechnology Co., LTD. - Recent Pipeline Updates, 2015
  • Genovate Biotechnology Co., LTD. - Dormant Developmental Projects,2015

List of Figures

  • Genovate Biotechnology Co., LTD. - Pipeline by Top 10 Indication, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Stage of Development, 2015
  • Genovate Biotechnology Co., LTD. - Monotherapy Products in Pipeline, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Top 10 Target, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Top 10 Route of Administration, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline by Top 10 Molecule Type, 2015
  • Genovate Biotechnology Co., LTD. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top